SynthesisVaccine2023

Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes.

Yuxuan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.